LSE:AZN (AstraZeneca PLC)
About AZN
AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.
AstraZeneca PLC (LSE: AZN) Latest News
Growth Shares
Is this FTSE 100 behemoth a no-brainer AI stock?
Investing Articles
With 13% annual earnings growth forecast and 45% under ‘fair value’, should I buy more of this FTSE giant now?
Investing Articles
FTSE Shares: 2 solid picks to consider when starting an ISA
Investing Articles
Prediction: analysts think the AstraZeneca share price will do this in 2026
Investing Articles
I asked ChatGPT for its top FTSE 100 stock for 2026, and it said…
Investing Articles
I asked ChatGPT for the best FTSE 100 shares to consider for 2026, and it said…
Investing Articles
Is 2026 the year it all goes wrong for the Rolls-Royce share price?
Investing Articles
Which stock market is best: the UK or US? Here’s how British investors can benefit regardless
Investing Articles
This UK share’s outperforming Nvidia. Is it time to buy?
Investing Articles
Are these 2 of the most profitable UK stocks on the FTSE 100? My money says ‘yes’
Investing Articles
This AI-adjacent FTSE 100 stock could be good to consider for a Stocks and Shares ISA